1.Single chain antibody fragment display systems: a review.
Yao CHEN ; Xingfu SHU ; Yu ZHAO ; Bowen ZHANG ; Zhongren MA ; Haixia ZHANG
Chinese Journal of Biotechnology 2023;39(9):3681-3694
Single chain antibody fragment (scFv) is a small molecule composed of a variable region of heavy chain (VH) and a variable region of light chain (VL) of an antibody, and these two chains are connected by a flexible short peptide. scFv is the smallest functional fragment with complete antigen-binding activity, which contains both the antibody-recognizing site and the antigen-binding site. Compared with other antibodies, scFv has the advantages of small molecular weight, strong penetration, low immunogenicity, and easy expression. Currently, the most commonly used display systems for scFv mainly include the phage display system, ribosome display system, mRNA display system, yeast cell surface display system and mammalian cell display system. In recent years, with the development of scFv in the field of medicine, biology, and food safety, they have also attracted much attention in the sectors of biosynthesis and applied research. This review summarizes the advances of scFv display systems in recent years in order to facilitate scFv screening and application.
Animals
;
Immunoglobulin Variable Region/genetics*
;
Immunoglobulin Fragments/metabolism*
;
Single-Chain Antibodies/metabolism*
;
Peptide Library
;
Mammals/genetics*
2.Expression of a human single-chain Fv antibody against HBsAg in Pichia pastoris.
Sheng XIONG ; Xiang-Rong REN ; Yong-Hong TANG ; Kuan-Yuan SU ; Zhou-Yao YU ; Yong LUO ; Yi-Fei WANG ; Jiu-Xiang LI
Chinese Journal of Biotechnology 2003;19(1):19-23
To express and secrete native HBscFv (anti-HBsAg single-chain Fv) in P. pastoris, HBscFv was amplified from plasmid pGEM-HBscFv, and then sub-cloned into expression vector pPICZalphaA. The resulting plasmid pPIC-HBscFv was linearized and transformed into P. pastoris GS115. The recombinant Pichia strains, identified by direct PCR and Zeocin-resistant screening of Pichia transformants, were cultured and induced with methanol. It was found that recombinant HBscFv, lead by alpha-factor, could be secreted into the culture supernatant to a level of 80mg/L. The bioactivity of Pichia produced HBscFv was confirmed by indirect ELISA, which also suggested that the bioactivity of HBscFv in the culture supernatant reached its peak in 72h and decreased in the late-stage of the induction. PAS staining suggests that HBscFv produced by yeast is poorly glycosylated or none-glycosylated protein.
Blotting, Western
;
Electrophoresis, Polyacrylamide Gel
;
Hepatitis B Surface Antigens
;
immunology
;
Humans
;
Pichia
;
genetics
;
metabolism
;
Polymerase Chain Reaction
;
Single-Chain Antibodies
;
genetics
;
immunology
;
metabolism
3.Preparation and identification of scFv and bsFv against transferrin receptor.
Jing, LIU ; Daiwen, XIAO ; Xiaoou, ZHOU ; Xue, WEN ; Hong, DAI ; Zhihua, WANG ; Xin, SHEN ; Wei, DAI ; Daofeng, YANG ; Guanxin, SHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2008;28(6):621-5
To obtain single chain variable fragment (scFv) and bivalent single chain variable fragment (bsFv) against transferrin receptor, up-stream and down-stream primers were designed according to the complementary sequences of FR1 region of variable heavy (VH) and FR4 of variable light (VL), respectively, which contained inter-linker G4S and the restriction endonuclease SfiI, AscI and NotI. Two pieces of scFv fragments were first amplified through PCR and then inserted into plasmid pAB1, which could express scFv protein once induced by IPTG in the host bacteria. To express scFv and bsFv, E. coli TG1 was cultured in LB broth and was induced by IPTG. The restriction enzyme digestion map and DNA sequencing demonstrated that scFv and bsFv genes were successfully inserted into the expression plasmid. SDS-PAGE and Western blotting revealed the protein band at 35kD and 60kD, which were consistent with the molecular weight of scFv and bsFv respectively. Flow cytometry showed that scFv and bsFv harbored the specific binding activity with TfR expressed in various tumor cells, and the avidity of bsFv was higher than that of the parent scFv.
Base Sequence
;
Cloning, Molecular
;
Escherichia coli/genetics
;
Escherichia coli/metabolism
;
Genetic Vectors/genetics
;
Hep G2 Cells
;
K562 Cells
;
Molecular Sequence Data
;
Receptors, Transferrin/*immunology
;
Recombinant Fusion Proteins/biosynthesis
;
Recombinant Fusion Proteins/genetics
;
Single-Chain Antibodies/*biosynthesis
;
Single-Chain Antibodies/genetics
4.The study of in vitro refolding conditions for humanized anti-CTLA4-scFv expressed in E. coli.
Lingyu ZENG ; Qiang HUANG ; Lihong CHEN ; Lin WAN ; Xiaofeng LU
Journal of Biomedical Engineering 2005;22(3):588-592
The purpose of the study is to explore the in vitro refolding protocol for humanized anti-CTLA4-scFv expressed in E. coli. The inclusion bodies are denatured and then diluted or dialyzed into a refolding buffer. We analyzed several factors affecting the refolding yield, including refolding time, temperature, and redox environment. The refolded target proteins are analyzed by non-reducing SDS-PAGE, and the concentration of refolded proteins are examined by Bio-Rad Dc Protein Assay kit. The result shows that a high yield of the protein with natural conformation can be acquired in the condition of 0.15 mol x L(-1) sodium chloride, 50 mmol x L(-1) Tirs-HCl, pH 8.0 buffer containing 1 micromol x L(-1) reduced glutathione and 3 micromol x L(-1) oxidized glutathione. The refolding time is 48 to 54 h at 4 degrees C. 28 mg refolded proteins are produced from 3.9g E. coli.
Antibodies, Monoclonal, Humanized
;
chemistry
;
CTLA-4 Antigen
;
chemistry
;
Escherichia coli
;
metabolism
;
Humans
;
Inclusion Bodies
;
chemistry
;
Protein Folding
;
Single-Chain Antibodies
;
chemistry
5.Construction and expression of an anti-EGFR/anti-KDR bispecific single-chain diabody.
Ya-qiong ZHOU ; Juan ZHANG ; Hai-zhen JIN ; Yuan HE ; Tong WANG ; Min WANG
Acta Pharmaceutica Sinica 2012;47(10):1317-1322
Bispecific antibodies have been exploited as both cancer immunodiagnostics and cancer therapeutics, which have shown promises in clinical trials in cancer imaging and therapy. To improve the anti-tumor effect, an scDb (bispecific single-chain diabody) was constructed from the variable domain genes of two scFvs (single-chain variable fragment antibodies) directed against human EGFR (epidermal growth factor receptor) and VEGFR2 (vascular endothelial growth factor receptor 2) extracellular domains. The anti-EGFR/ anti-KDR scDb was constructed into pHEN2 plasmid and expressed in Escherichia coli HB2151 host. After purification by one-step affinity chromatography of IMAC, scDb protein was characterized by Western blotting. The yield of scDb protein was 570 microg per liter medium. scDb bound to EGFR as efficiently as the parental antibody scFv-E10, while a little bit weaker than the parental antibody scFv-AK404R when bound to KDR. In conclusion, the scDb protein could bind both EGFR and KDR specifically and could be applied for further anti-tumor research.
Antibodies, Bispecific
;
biosynthesis
;
genetics
;
Escherichia coli
;
metabolism
;
Humans
;
Plasmids
;
Protein Binding
;
Receptor, Epidermal Growth Factor
;
immunology
;
Single-Chain Antibodies
;
biosynthesis
;
genetics
;
Vascular Endothelial Growth Factor Receptor-2
;
immunology
6.Biological activity of human single-chain antibody against amyloid beta peptide involved in Alzheimer's disease.
Jiong CAI ; Fang LI ; Fei LIU ; Shi-zhen WANG
Acta Academiae Medicinae Sinicae 2007;29(5):647-650
OBJECTIVETo explore the biological activity of recombinant human single-chain antibody against amyloid beta peptide in vitro.
METHODSHuman single-chain antibody against amyloid beta peptide was obtained from recombinant bacteria. The antigen-binding activity of this antibody was measured by enzyme-linked immunosorbent assay (ELISA) and competitive ELISA. Human neuroblastoma SH-SY5Y cells were used as cell models to test the protective role of human single-chain antibody against amyloid beta peptide.
RESULTSRecombinant human single-chain antibody was mainly located in the insoluble inclusion bodies of bacteria. The antibody was dissolved by urea and purified by metal affinity chromatography as active form to bind synthetic amyloid beta peptide 40 or amyloid beta peptide 42. The improvement of the survival rates of human neuroblastoma cells was significantly superior in amyloid peptide 42 plus equimolar antibody group than in amyloid peptide 42 group (P < 0.05), and was significantly superior in the amyloid peptide 40 plus equimolar antibody group than in amyloid peptide 40 group (P < 0.01).
CONCLUSIONThe recombinant human single-chain antibody against beta amyloid peptide 40 from E. coli can partially inhibit the neurotoxicity effect of amyloid beta peptide in vitro.
Amyloid beta-Peptides ; immunology ; metabolism ; toxicity ; Cell Line, Tumor ; Cell Survival ; drug effects ; Humans ; Peptide Fragments ; metabolism ; toxicity ; Protein Binding ; Recombinant Proteins ; pharmacology ; Single-Chain Antibodies ; pharmacology
7.Effect of antibody CR6261 V(H) and scFv expression on influenza virus infection.
Yan LI ; Xiulan LI ; Jinghua YAN
Chinese Journal of Biotechnology 2011;27(10):1472-1481
The emerging CR6261 antibody could neutralize several subtype influenza virus with high affinity, whose VH domain binds to the HA protein conserved domain. Therefore, it has drawn much attention as a potential broad-spectrum therapeutic antibody against influenza virus. In this study, we constructed the eukaryotic expression vectors pCR6261V(H), pCR6261V(H)-GFP and pCR6261scFv and screened the monoclonal cell lines that could stably express CR6261V(H), CR6261V(H)-GFP and CR6261scFv on the cell membrane. After influenza virus infecting the stable cell lines, the titers of viruses were tested by hemagglutination inhibition test. The result shows that the titers of viruses in CR6261scFv and CR6261V(H)-GFP stable expression cell lines decreased and there was no obvious discrimination between the CR6261V(H) expression cell line and the negative control, suggesting that CR6261V(H) and CR6261scFv expressing on the cell membrane could partly inhibit the virus infection. Though the effective inhibition strategy is undergoing, our research will provide new clues for the breeding of anti influenza transgenic animals.
Antibodies, Monoclonal
;
immunology
;
Antibodies, Viral
;
chemistry
;
immunology
;
Antibody Specificity
;
Cell Line
;
Genetic Vectors
;
Hemagglutinin Glycoproteins, Influenza Virus
;
chemistry
;
immunology
;
metabolism
;
Humans
;
Influenza, Human
;
immunology
;
Orthomyxoviridae
;
drug effects
;
immunology
;
Single-Chain Antibodies
;
immunology
8.Expression of anti-gp96 scFv fragment in Pichia pastoris and identification of its biological activity.
Mingming GUI ; Huiying WU ; Lu SUN ; Yaxing XU ; Bao ZHAO ; Xin LI ; Changfei LI ; Xidong WANG ; Songdong MENG
Chinese Journal of Biotechnology 2014;30(4):595-604
Secretory anti-gp96 scFv fragment was expressed in Pichia pastoris to obtain a small molecule antibody that specifically recognizes heat shock protein gp96. The gp96-scFv fragment gene was synthesized and cloned to Pichia pastoris expression plasmid pPICZa-A. Pichia pastoris X33 was electroporated with the linearized recombinant expression vector, and expression of gp96-scFv fragment was induced by methanol. The His-tagged recombinant protein was then purified by affinity chromatography and analyzed with SDS-PAGE and Western blotting assays. The biological activities of recombinant gp96-scFv fragment were determined by Western blotting, Immunofluorescence, ELISA and FACS assays. The gp96-scFv fragment was expressed successfully in Pichia pastoris. About 50 mg of recombinant protein could be purified from 1 liter of the Pichia pastoris culture supernatant. Its molecular weight was about 15 kDa. The gp96-scFv fragment could specifically bind to gp96 protein by Western blotting, immunofluorescence, ELISA and FACS analyses. Pichia pastoris-expressed gp96-scFv fragment specifically recognizes gp96 protein, which could be used for Western blotting, Immunofluorescence, ELISA and FACS analyses.
Blotting, Western
;
Chromatography, Affinity
;
Electrophoresis, Polyacrylamide Gel
;
Enzyme-Linked Immunosorbent Assay
;
Membrane Glycoproteins
;
immunology
;
Pichia
;
metabolism
;
Plasmids
;
Recombinant Proteins
;
biosynthesis
;
Single-Chain Antibodies
;
biosynthesis
9.Optimization of the preparation process for fusion protein Fv-LDP that composes lidamycin apoprotein and single-chain Fv antibody directed against type IV collagenase.
Rui-Juan GAO ; Chun-Yan ZHAO ; Dian-Dong LI ; Yong-Su ZHEN
Acta Pharmaceutica Sinica 2013;48(10):1563-1569
This study is to optimize the preparation process of fusion protein Fv-LDP which was expressed in the form of inclusion body and consisted of lidamycin apoprotein LDP and single-chain Fv antibody (scFv) directed against type IV collagenase. The preparation and the dissolution of inclusion body, the immobilized metal affinity chromatography of the target protein and the renaturization by stepwise dialysis were optimized by single-factor analysis or orthogonal design. In addition, the refolded fusion protein Fv-LDP was refined by Sephadex G-75 chromatography followed by fluorescence-activated cell sorter (FACS)-based saturation binding assay to measure its antigen-binding activity. After optimization of the process, the purity of fusion protein Fv-LDP existed in the inclusion body was 63.9% and the corresponding solubility was 95.7%; Under denaturing conditions, the purity of fusion protein Fv-LDP was more than 95% after the purification process. The percentage of monomeric fusion protein Fv-LDP was 60% after the refolding process, while it was further refined to 85% which was 5.6-fold higher than that of the initial refolding condition. The refined fusion protein Fv-LDP could bind to human lung adenocarcinoma PAa cells and human hepatoma BEL-7402 cells with the dissociation constants (Kd) of 0.176 micromol x L(-1) and 0.904 micromol x L(-1), respectively. The preparation process of fusion protein Fv-LDP has been successfully optimized, which provides the experimental basis for the production and future development of fusion protein Fv-LDP, and might serve as a relatively practical system for the preparation of other scFv-based proteins expressed in the form of inclusion body.
Adenocarcinoma
;
metabolism
;
pathology
;
Aminoglycosides
;
chemistry
;
metabolism
;
Antibiotics, Antineoplastic
;
chemistry
;
metabolism
;
Apoproteins
;
chemistry
;
metabolism
;
Carcinoma, Hepatocellular
;
metabolism
;
pathology
;
Cell Line, Tumor
;
Collagenases
;
immunology
;
Enediynes
;
chemistry
;
metabolism
;
Escherichia coli
;
chemistry
;
metabolism
;
Humans
;
Inclusion Bodies
;
chemistry
;
metabolism
;
Liver Neoplasms
;
metabolism
;
pathology
;
Lung Neoplasms
;
metabolism
;
pathology
;
Protein Binding
;
Recombinant Fusion Proteins
;
chemistry
;
metabolism
;
Single-Chain Antibodies
;
chemistry
;
metabolism
10.Optimizing the host bacteria to make a large naive phage antibody library in the recombination system.
Wei SUN ; Heng LIN ; Fang HUA ; Zhuo-Wei HU
Acta Pharmaceutica Sinica 2013;48(1):66-70
To prepare large naive phage antibody library, the host bacteria with high transformation efficiency is used in the Cre-LoxP recombination system. The variable regions of immunoglobulin light and heavy genes were amplified from lymphocytes collected from adult peripheral blood and newborn cord blood. The genes were spliced to form the single-chain variable fragments (scFv) by overlap PCR, cloned into pDAN5a vector and then transformed into XL2-blue MRF' with the Hte gene. Compared with XL1-blue strain, the size of the primary library was increased by 3.9 times. The primary library infected Cre recombinase-expressing bacteria, and the genes between phagemids created many new VH/VL combinations. The library was calculated to have a diversity of 1.7 x 10(11) and validated by the selection of antibodies against six different protein antigens. This library provides the basis for further selection of antibody-based drugs. It is the first time to report that XL2-blue MRF' can be used to improve the diversity of the library in the recombination system.
Adult
;
Escherichia coli
;
genetics
;
immunology
;
Genetic Vectors
;
Humans
;
Immunoglobulin Heavy Chains
;
genetics
;
Immunoglobulin Light Chains
;
genetics
;
Immunoglobulin Variable Region
;
genetics
;
Infant, Newborn
;
Integrases
;
metabolism
;
Lymphocytes
;
immunology
;
Peptide Library
;
Recombination, Genetic
;
genetics
;
Single-Chain Antibodies
;
genetics
;
metabolism
;
Transformation, Genetic